ID: ALA429181

Max Phase: Preclinical

Molecular Formula: C102H168N34O22

Molecular Weight: 2222.68

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CCNC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C=O)C(C)C

Standard InChI:  InChI=1S/C102H168N34O22/c1-9-58(6)80(91(151)120-63(23-12-39-114-99(104)105)82(142)126-70(53-137)56(2)3)129-89(149)76-31-19-46-133(76)95(155)66(25-14-41-116-101(108)109)122-86(146)73-28-18-48-135(73)97(157)69(51-61-52-113-55-118-61)125-84(144)71(54-138)127-92(152)81(59(7)139)130-90(150)77-32-20-47-134(77)96(156)67(26-15-42-117-102(110)111)123-87(147)75-30-21-49-136(75)98(158)79(57(4)5)128-83(143)68(50-60-33-35-62(140)36-34-60)124-88(148)74-29-17-45-132(74)94(154)65(24-13-40-115-100(106)107)121-85(145)72-27-16-44-131(72)93(153)64(22-10-11-38-103)119-78(141)37-43-112-8/h33-36,52-53,55-59,63-77,79-81,112,138-140H,9-32,37-51,54,103H2,1-8H3,(H,113,118)(H,119,141)(H,120,151)(H,121,145)(H,122,146)(H,123,147)(H,124,148)(H,125,144)(H,126,142)(H,127,152)(H,128,143)(H,129,149)(H,130,150)(H4,104,105,114)(H4,106,107,115)(H4,108,109,116)(H4,110,111,117)/t58-,59+,63-,64-,65-,66-,67-,68-,69-,70+,71-,72-,73-,74-,75-,76-,77-,79-,80-,81-/m0/s1

Standard InChI Key:  KPCUEKUUAOPMOC-KVJQSOGOSA-N

Associated Targets(Human)

Cell line 371 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Escherichia coli 133304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 2222.68Molecular Weight (Monoisotopic): 2221.3072AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. de Visser PC, van Hooft PA, de Vries AM, de Jong A, van der Marel GA, Overkleeft HS, Noort D..  (2005)  Biological evaluation of Tyr6 and Ser7 modified drosocin analogues.,  15  (11): [PMID:15911277] [10.1016/j.bmcl.2005.03.074]

Source